Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$751K Hold
3,397
0.32% 76
2025
Q4
$861K Hold
3,397
0.38% 67
2025
Q3
$841K Hold
3,397
0.38% 71
2025
Q2
$816K Hold
3,397
0.39% 80
2025
Q1
$770K Hold
3,397
0.41% 77
2024
Q4
$698K Hold
3,397
0.36% 86
2024
Q3
$824K Hold
3,397
0.4% 78
2024
Q2
$746K Hold
3,397
0.37% 87
2024
Q1
$764K Hold
3,397
0.37% 87
2023
Q4
$747K Hold
3,397
0.4% 87
2023
Q3
$745K Hold
3,397
0.53% 67
2023
Q2
$764K Hold
3,397
0.47% 72
2023
Q1
$650K Buy
+3,397
New +$657K 0.42% 85

Other funds holding STE

Matisse Capital's STE Position: Q1 2026 in Review

Matisse Capital held its Steris (STE) position steady in Q1 2026 at 3,397 shares worth $751K. The position accounts for 0.32% of the portfolio, ranked #76.

Matisse Capital first reported a position in STE in Q1 2023 and has held it in 13 quarters since. The position peaked at $861K in Q4 2025. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Matisse Capital held 3,397 shares of Steris worth $751K as of Q1 2026.
  • Matisse Capital left its Steris share count unchanged in Q1 2026.
  • Steris made up 0.32% of Matisse Capital's portfolio in Q1 2026, its #76 holding.
  • Matisse Capital first reported a position in Steris in Q1 2023 and has held it in 13 quarters since.
  • Matisse Capital's Steris position peaked at $861K in Q4 2025.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Matisse Capital's 13F filing for Q1 2026, filed 8 May 2026.